Patient Guide: A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 171 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05953480
Status: 🟢 Enrolling Now
Condition: Acute Ischemic Stroke
Phase: PHASE2

Where You Can Participate

This study is available at 171 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Sarasota, Florida
  • • Augusta, Georgia
  • • And 168 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke - Join Clinical Trial NCTNCT05953480

How to Join This Clinical Trial - NCTNCT05953480

Learn how to participate in this PHASE2 trial studying an investigational therapy for Acute Ischemic Stroke. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Acute Ischemic Stroke. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Acute Ischemic Stroke
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05953480 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 171 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85724 - United States

Status: RECRUITING

Clinical Research Site

Sarasota, Florida 34239-3228 - United States

Status: RECRUITING

Clinical Research Site

Augusta, Georgia 30912-0004 - United States

Status: RECRUITING

Clinical Research Site

Rockford, Illinois 61114-2300 - United States

Status: RECRUITING

Clinical Research Site

Munster, Indiana 46321-2901 - United States

Status: RECRUITING

Clinical Research Site

Baltimore, Maryland 21215-5216 - United States

Status: RECRUITING

Clinical Research Site

Traverse City, Michigan 49684 - United States

Status: RECRUITING

Clinical Research Site

Rochester, Minnesota 55905-0001 - United States

Status: RECRUITING

Clinical Research Site

Great Neck, New York 11021-5338 - United States

Status: RECRUITING

Clinical Research Site

Manhasset, New York 11030-3816 - United States

Status: ACTIVE_NOT_RECRUITING

And 161 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Acute Ischemic Stroke:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships